Chronic myelogenous leukemia (CML) trials
The list below is a sampling of the many open BMT clinical trials for CML at University of Minnesota Medical Center, Fairview. Click on the highlighted links below for a printable PDF summary of selected studies. We will be adding new summaries in the future, so please be sure to visit us again. For information on additional trials, please call 612-273-2800.
Chronic Phase (drug resistant)
Allo Transplant for Heme Malignancy (MT2001-02)
Allo Transplant for CML (MT1982-12)
Reduced Intensity Allo Bone Marrow Transplant (MT2001-10)
Myeloablative UCB Transplant for Heme Malignancy (MT2005-10)
Reduced Intensity UCB Transplant (MT2005-02)
Expanded Human Myeloid Progenitor Cells post Allo UCB for Heme Malignancy (MT-2008-38)
Accelerated Phase
Allo Transplant for Heme Malignancy (MT2001-02)
Allo Transplant for CML (MT1982-12)
Reduced Intensity Allo Bone Marrow Transplant (MT2001-10)
Myeloablative UCB Transplant for Heme Malignancy (MT2005-10)
Patient Version: Myeloablative Umbilical Cord Blood Transplantation (2005-10)
Reduced Intensity UCB Transplant (MT2005-02)
Patient Version: Reduced Intensity Umbilical Cord Blood Transplantation (2005-02)
Expanded Human Myeloid Progenitor Cells post Allo UCB for Heme Malignancy (MT-2008-38)
UCB Tregs after Reduced Intensity Transplant (MT 2006-01)
CTN: Siro/Tac vs. Mtx/Tac for GVHD Prophylaxis (MT 2006-18)
Reduced Intensity UCB Transplant with C3a Priming (MT 2008-15)
Relapsed
